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The proteins responsible for biosynthesis, biodegradation, and transport of additional molecules, such as small 
metabolites, lipids and glycans, are encoded in the genome, which may indicate that all cellular functions are specified 
by the genomic DNA sequence. In practice, however, inferring higher-level systemic functions of the cell or the 
organism needs more than solely the genomic information. We are developing bioinformatics methods to integrate 
different types of data and knowledge on various aspects of the biological systems towards basic understanding of life 
as a molecular interaction/reaction system and also toward practical applications in medical and pharmaceutical sciences.








Databases available in the DBGET/LinkDB system of the GenomeNet 
service. Color of each database represents the type of its contents, yel-
low: systems information, purple: medical information, pink: genetic 
information, light blue: chemical information.
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Development of a Web-based Supervised 
Gene Network Inference Engine
Recent developments of biotechnologies, e.g., microarray 
and proteomics technologies, contribute to an increasing 
amount of high-throughput data for genes and proteins, 
which are useful sources to infer the biological networks 
on a large scale. We have developed GEne Network Infer-
ence Engine based on Supervised analysis (GENIES: 
http://www.genome.jp/tools/genies/), a web server to pre-
dict unknown part of gene network from various types of 
genome-wide data in the framework of supervised net-
work inference (Kotera et al., 2012). The originality of the 
supervised network inference method lies in construction 
of a predictive model using partially known network in-
formation, and in the integration of heterogeneous data 
with kernel methods. The method is suitable for predicting 
potential interactions involving uncharacterized genes and 
their associations with known pathways. The GENIES 
server accepts any profiles of genes or proteins (such as 
gene expression profiles, protein subcellular localization 
profiles and phylogenetic profiles), or pre-calculated gene-
gene similarity matrices (or kernels) in the tab-delimited 
file format. As a training data set to learn a predictive 
model, the users can choose either known molecular net-
work information in the KEGG Pathway database, or their 
own gene network data. The server provides the list of 
newly predicted gene pairs, maps the predicted gene pairs 
onto the associated pathway diagrams in KEGG Pathway, 
and indicates candidate genes for missing enzymes in 
 organism-specific metabolic pathways.
A Statistical Framework for Analyzing  
the Association between Drug Target Proteins 
and Drug Side-effects
Most drugs are small chemical compounds that target 
specific proteins to induce regulations of the overall pro-
tein networks, or pathways. This may result in expected 
therapeutic effects to the body, or occasionally undesired 
side-effects. Recently, several types of drug-related data 
have been accumulated in publicly available databases. 
Drug chemical structures, target proteins, and side-effects 
are such data types. Bioinformatics approaches are expected 
to be useful to retrieve important relationships between 
different types of data, which helps studies on the under-
lying mechanisms of drug-actions in a living system at 
different levels. Our lab has been focusing on storing such 
heterogeneous data in the form of relational database and 
developing related algorithms. Previously, we published a 
drug-drug interaction retrieval system in the KEGG 
DRUG database, which is a database-searching approach 
to comprehensively understand drug-drug interactions at 
the molecular scale (Takarabe et al., 2011). We took 
another approaches applying statistical methods, which 
link drug-protein interaction data at the molecular scale 
and their side-effects at the phenotypic scale. As one of 
our recent studies (Mizutani et al., 2012), we applied the 
sparse canonical correlation analysis (SCCA) to a drug-
protein interaction data in a framework of predicting 
potential side-effects for a set of drugs (Figure 2). This 
resulted in an extraction of target proteins and side-effects 
in the form of correlated sets (Figure 3). A following 
pathway enrichment analysis using KEGG and Gene 
Ontology (GO) databases showed that proteins of similar 
biological processes were clustered together in the same 
extracted correlated sets, even if their molecular functions 
were different. In another study (Takarabe et al., 2012), 
we used similar approach to retrieve biologically relevant 
interpretations from the drug-target-side-effect associations. 
We believe our continuous efforts help promote discussions 
over the molecular mechanisms of drug side-effects and 
underlying biological knowledge.
Figure 1. The workflow of GENIES.
Figure 2. SCCA extracts correlated sets of target proteins and side-
effects .
Figure 3. An illustration of the network of drug targeted proteins and 
side-effects in the extracted correlated sets (CSs).
